Tumor Necrosis Factor-a-Induced Lung Injury and Its Modulation by Synthetic Polynucleotide: A Physiologic-Morphometric Analysis

References

• Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci. 1975; 72: 3666–3670
   PubMed Web of Science ®Google Scholar
• Tracey KJ, Beutler B, Lowry SF. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–473
   PubMed Web of Science ®Google Scholar
• Hesse DG, Tracey KJ, Fong Y. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet. 1988; 166: 147–153
   PubMedGoogle Scholar
• Calandra T, Baumgartner J, Grau GE. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis. 1990; 161: 982–987
   PubMed Web of Science ®Google Scholar
• Huang YC, Kennedy TP, Su YF, Watkins WD, Whorton AR, Piantadosi CA. Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lungs. J Appl Physiol. 1993; 74: 251–258
   PubMed Web of Science ®Google Scholar
• Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med. 1987; 166: 1390–1404
   PubMed Web of Science ®Google Scholar
• Valone FH, Epstein LB. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1β, tumor necrosis factor, or IFN-γ. J Immunol 1988; 141: 3945–3950
   PubMed Web of Science ®Google Scholar
• Bussolino F, Camussi G, Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor in interleukin la. J Biol Chem. 1988; 263: 11856–11861
   PubMed Web of Science ®Google Scholar
• Dawson CA, Linehan JH, Rickaby DA. Pulmonary microcirculatory hemodynamics. Ann NY Acad Sci. 1982; 384: 90–106
   PubMed Web of Science ®Google Scholar
• Townsley MI, Korthuis RJ, Rippe B, Parker JC, Taylor AE. Validation of double occlusion method for Pc,i in lung and skeletal muscle. J Appl Physiol. 1986; 61: 127–132
   PubMed Web of Science ®Google Scholar
• Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol. 1985; 59: 1978–1985
   PubMed Web of Science ®Google Scholar
• Hales CA, Soune L, Peterson M, Kong D, Miller M, Watkins WD. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest. 1981; 68: 497–505
   PubMed Web of Science ®Google Scholar
• Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974; 20(10)1255–1270
   PubMed Web of Science ®Google Scholar
• Weibel ER, Bolender RP. Stereological techniques for electron microscopic morphometry. Principle and Techniques of Electron Microscopy, MA Hayat. Van Nostrand, New York 1989
   Google Scholar
• Underwood EE. Quantitative stereology. Addison-Wesley, Reading, MA 1970
   Google Scholar
• Crapo JD, Peters-Golden M, Marsh-Salin J, Shelburne JS. Pathologic changes in the lungs of oxygen-adapted rats: a morphometric analysis. Lab Invest. 1978; 39: 640–653
   PubMed Web of Science ®Google Scholar
• Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult insufficiency associated with septicemia. Am Rev Respir Dis. 1977; 116: 589
   PubMed Web of Science ®Google Scholar
• Kettlehut IC, Fiers W, Goldberg AL. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci. 1987; 84: 4273–4277
   PubMed Web of Science ®Google Scholar
• Michie HR, Manogue KR, Spriggs DR. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988; 318: 1481–1486
   PubMed Web of Science ®Google Scholar
• Marks JD, Marks CB, Luce JM. Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis. 1990; 141: 94–97
   PubMed Web of Science ®Google Scholar
• Maunder RJ, Hackman RC, Riff E, Albert RK, Springmeyer SC. Occurrence of the adult respiratory distress syndrome in neuropenic patients. Am Rev Respir Dis. 1986; 133: 313–316
   PubMed Web of Science ®Google Scholar
• Ognibene FP, Martin SE, Parker MM. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med. 1986; 315: 547–551
   PubMed Web of Science ®Google Scholar
• Laufe MD, Simon RH, Flint A, Keller JB. Adult respiratory distress syndrome in neuropenic patients. Am J Med. 1986; 80: 1022–1026
   PubMed Web of Science ®Google Scholar
• Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis. 1988; 137: 1364–1370
   PubMed Web of Science ®Google Scholar
• Stephens KE, Ishizaka A, Wu Z, Larrick JW, Raffin TA. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am Rev Respir Dis. 1988; 138: 1300–1307
   PubMed Web of Science ®Google Scholar
• Johnson J, Brigham KL, Jesmok G, Meyrick B. Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor α. Am Rev Respir Dis. 1991; 144: 179–186
   PubMed Web of Science ®Google Scholar
• Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state in rabbits. J Clin Invest. 1988; 81: 1162–1172
   PubMed Web of Science ®Google Scholar
• Goldblum SE, Hennig B, May M, Yoneda K, McClain CG. Tumor necrosis factor α-induced pulmonary vascular endothelial injury. Infect Immun. 1989; 57: 1218–1226
   PubMed Web of Science ®Google Scholar
• Horvath CJ, Ferro TJ, Jesmok G, Malik AB. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci. 1988; 85: 9219–9223
   PubMed Web of Science ®Google Scholar
• Johnson J, Meyrick B, Jesmok G, Brigham KL. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J Appl Physiol. 1989; 66: 1448–1454
   PubMed Web of Science ®Google Scholar
• Turner CR, Esser KM, Wheeldon EB, Slivjak M, Smith EF, III. Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rats. Circ Shock. 1989; 28: 369–384
   PubMedGoogle Scholar
• Carlos T, Kovach N, Schwartz B. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood. 1991; 77: 2266–2271
   PubMed Web of Science ®Google Scholar
• Hughes C CW, Male DK, Lantos PL. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-γ tumor necrosis factor and inter-leukin-1. Immunology 1988; 64: 677–681
   PubMed Web of Science ®Google Scholar
• Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol. 1988; 107: 321–331
   PubMed Web of Science ®Google Scholar
• Osborn L, Hession C, Tizard R. Direct expression cloning of vascular cell adhesion molecule 1 a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203–1211
   PubMed Web of Science ®Google Scholar
• Carlos TM, Schwartz BR, Kovach NL. Vascular cell adhesion molecule-1 (VCAM-1) mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 1990; 76: 965–970
   PubMed Web of Science ®Google Scholar
• Mushtaha AA, Schmalstieg FC, Hughes TK, Jr, Rudloff HE, Goldman AS. Chemokinetic effects of exogenous and endogenous tumor necrosis factor alpha on human blood monocytes. Int Arch Allergy Appl Immunol. 1989; 90: 11–15
   PubMedGoogle Scholar
• Maghazachi AA. Tumor necrosis factor-α is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate. J Leuko Biol. 1991; 49: 302–308
   PubMed Web of Science ®Google Scholar
• Ming WJ, Bersani L, Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1989; 138: 1469–1474
   Web of Science ®Google Scholar
• Issekutz TB, Stoltz JM. Stimulation of lymphocyte migration by endotoxin, tumor necrosis factor, and interferon. Cell Immunol. 1989; 120: 165–173
   PubMed Web of Science ®Google Scholar
• Gaynor E. Increased mitotic activity in rabbits endothelium after endotoxin: an autoradiographic study. Lab Invest. 1971; 24: 318–320
   PubMed Web of Science ®Google Scholar
• Look DC, Rapp SR, Keller BT, Holtzman MJ. Selective induction of intercellular adhesion molecule-1 by interferon-γ in human airway epithelial cells. Am J Physiol. 1992; 263: L79–L87
   PubMed Web of Science ®Google Scholar
• Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986; 137: 245–254
   PubMed Web of Science ®Google Scholar
• Kikkawa Y, Yano S, Skoza L. Protective effect of interferon inducers against hyperoxic pulmonary damage. Lab Invest. 1984; 50: 62–71
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H, Kumae T, Kikkawa Y. Effect of interferon inducers on superoxide anion generation from rat liver microsomes detected by lucigenin chemiluminescence. Biochem Biophys Res Commun. 1989; 161: 1042–1048
   PubMed Web of Science ®Google Scholar
• Gessani S, McCandless S, Baglioni C. Downregulation of tumor necrosis factor receptors of macrophages by interferons and interleukin-1: role of protein kinase C activation. J Biol Reg Homeo Agents 1988; 2: 166–172
   PubMed Web of Science ®Google Scholar